Detalhe da pesquisa
1.
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.
Nat Immunol;
23(9): 1379-1392, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36002648
2.
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer.
J Transl Med;
21(1): 843, 2023 11 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37996891
3.
Replication stress response in cancer stem cells as a target for chemotherapy.
Semin Cancer Biol;
53: 31-41, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30081229
4.
CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells.
Gut;
67(5): 903-917, 2018 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28389531
5.
In Vitro Evaluation of Cancer Cell Immunogenicity and Antigen-Specific T-Cell Cytotoxicity by Flow Cytometry.
Methods Mol Biol;
2748: 13-28, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38070104
6.
Epigenetics behind tumor immunology: a mini review.
Oncogene;
42(39): 2932-2938, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37604925
7.
3D cancer models: One step closer to in vitro human studies.
Front Immunol;
14: 1175503, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37114038
8.
The Yin and Yang of Type I IFNs in Cancer Promotion and Immune Activation.
Biology (Basel);
10(9)2021 Sep 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34571733
9.
The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure.
Cells;
10(9)2021 09 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34572009
10.
Actin Cytoskeleton Dynamics and Type I IFN-Mediated Immune Response: A Dangerous Liaison in Cancer?
Biology (Basel);
10(9)2021 Sep 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34571790
11.
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments.
J Vis Exp;
(170)2021 04 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33999026
12.
The Targeting of MRE11 or RAD51 Sensitizes Colorectal Cancer Stem Cells to CHK1 Inhibition.
Cancers (Basel);
13(8)2021 Apr 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33921638
13.
Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51.
Cell Death Differ;
28(7): 2060-2082, 2021 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33531658
14.
Assessment of IFN-γ and granzyme-B production by in "sitro" technology.
Methods Enzymol;
631: 391-414, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31948559
15.
Cytofluorometric assessment of dendritic cell-mediated uptake of cancer cell apoptotic bodies.
Methods Enzymol;
632: 39-54, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32000907
16.
Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening.
Front Immunol;
11: 2166, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33193295
17.
Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications.
Oncoimmunology;
6(5): e1314424, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28638743
18.
IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer.
Oncotarget;
7(18): 26361-73, 2016 May 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27028869